Modithromycin

DB16238InvestigationalSmall molecule

Modithromycin is under investigation in clinical trial NCT00270517 (Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia).

Formula / weight: C₄₃H₆₄N₆O₁₁ · 841.016 g/mol (avg)
Code names: EDP-013420 · EDP-420 · EP-13420

Resolves to

Compound

UNII9MAY4E090UCAS736992-12-4ChEMBLCHEMBL263886

Structure

InChIKeyWLGSYOKBEDVHQB-XSKCQLPHSA-NSMILES

[H][C@@]1(O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@@H]2OC\C(CO[C@]1(C)C[C@@H](C)\C(=N/C(C)=O)[C@@H]2C)=N/OCC1=CN=C(C=C1)N1C=CC=N1

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Modithromycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account